AbbVie Inc. sell NightTrain
Start price
19.11.20
/
50%
€83.50
Target price
19.11.21
-
Performance (%)
2.98%
End price
11.02.21
€85.99
Summary
This prediction ended on 11.02.21 with a price of €85.99. The SELL prediction by NightTrain shows the price for AbbVie Inc. slightly increased by 2.98% during the runtime of the prediction. A total of €1.08 was paid as dividends for this prediction. NightTrain has 50% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AbbVie Inc. | -0.909% | -0.909% | 6.410% | 71.797% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by NightTrain for this prediction
In the thread AbbVie Inc. diskutieren
Sell AbbVie Inc.